ACE-inhibitor 发表于 2025-3-23 11:39:29

http://reply.papertrans.cn/29/2849/284834/284834_11.png

核心 发表于 2025-3-23 17:52:25

http://reply.papertrans.cn/29/2849/284834/284834_12.png

Peristalsis 发表于 2025-3-23 21:54:58

Mohammed TariqueReviews novel molecular targets for antimalarial drug development.Explores metabolic enzymes as druggable targets against malaria.Examines Plasmodium Kinases as potential drug targets for malaria

GUISE 发表于 2025-3-23 23:31:45

http://image.papertrans.cn/e/image/284834.jpg

LATHE 发表于 2025-3-24 05:24:01

Vitamin D Assays and Their Clinical Utility,untries, it poses serious clinical and economic challenges. Malaria is caused by parasitic organisms of the genus Plasmodium, which are single-celled protozoans. In addition to humans, these parasites infect a wide variety of other species. There are more than 200 formally characterized species of P

让步 发表于 2025-3-24 07:37:44

http://reply.papertrans.cn/29/2849/284834/284834_16.png

Cerebrovascular 发表于 2025-3-24 12:56:31

http://reply.papertrans.cn/29/2849/284834/284834_17.png

projectile 发表于 2025-3-24 16:48:40

http://reply.papertrans.cn/29/2849/284834/284834_18.png

不透明 发表于 2025-3-24 22:03:37

http://reply.papertrans.cn/29/2849/284834/284834_19.png

PLAYS 发表于 2025-3-25 02:34:55

Onyeka Obioha,Candrice Heath,Pearl E. Grimescancer, immune deficiencies, viral infection, and neurodegenerative disease leading to the successful clinical development of effective and selective inhibitors of phosphoinositide kinases. However, targeting of phosphoinositide kinases is most effective for plasmodium to treat malaria. The phosphat
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives; Mohammed Tarique Book 2024 The Editor(s) (if applicable) and The